Head and Neck Tumors: Assessment of Perfusion-Related Parameters and Diffusion Coefficients Based on the Intravoxel Incoherent Motion Model

References

1. 1.↵
   1. Padhani AR,
   2. Liu G,
   3. Mu-Koh D,
   4. et al

   . Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 2009;11:102–25

   PubMedWeb of Science
2. 2.↵
   1. Le Bihan D

   . Looking into the functional architecture of the brain with diffusion MRI. Nat Rev Neurosci 2003;4:469–80

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Le Bihan D,
   2. Breton E,
   3. Lallemand D,
   4. et al

   . MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology 1986;161:401–07

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Le Bihan D,
   2. Breton E,
   3. Lallemand D,
   4. et al

   . Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 1988;168:497–505

   PubMedWeb of Science
5. 5.↵
   1. Luciani A,
   2. Vignaud A,
   3. Cavet M,
   4. et al

   . Liver cirrhosis: intravoxel incoherent motion MR imaging—pilot study. Radiology 2008;249:891–99

   CrossRefPubMed
6. 6.↵
   1. Moteki T,
   2. Horikoshi H

   . Evaluation of hepatic lesions and hepatic parenchyma using diffusion-weighted echo-planar MR with three values of gradient b-factor. J Magn Reson Imaging 2006;24:637–45

   CrossRefPubMed
7. 7.↵
   1. Coenegrachts K,
   2. Delanote J,
   3. Ter Beek L,
   4. et al

   . Evaluation of true diffusion, perfusion factor, and apparent diffusion coefficient in non-necrotic liver metastases and uncomplicated liver hemangiomas using black-blood echo planar imaging. Eur J Radiol 2009;69:131–38

   CrossRefPubMed
8. 8.↵
   1. Sumi M,
   2. Nakamura T

   . Diagnostic importance of focal defects in the apparent diffusion coefficient-based differentiation between lymphoma and squamous cell carcinoma nodes in the neck. Eur Radiol 2009;19:975–81

   PubMed
9. 9.↵
   1. Eida S,
   2. Sumi M,
   3. Sakihama N,
   4. et al

   . Apparent diffusion coefficient mapping of salivary gland tumors: prediction of the benignancy and malignancy. AJNR Am J Neuroradiol 2007;28:116–21

   Abstract/FREE Full Text
10. 10.↵
    1. Habermann CR,
    2. Arndt C,
    3. Graessner J,
    4. et al

    . Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? AJNR Am J Neuroradiol 2009;30:591–96

    Abstract/FREE Full Text
11. 11.↵
    1. Zima A,
    2. Carlos R,
    3. Gandhi D,
    4. et al

    . Can pretreatment CT perfusion predict response of advanced squamous cell carcinoma of the upper aerodigestive tract treated with induction chemotherapy? AJNR Am J Neuroradiol 2007;28:328–34

    Abstract/FREE Full Text
12. 12.↵
    1. Lewin M,
    2. Fartoux L,
    3. Vignaud A,
    4. et al

    . The diffusion-weighted imaging perfusion fraction f is a potential marker of sorafenib treatment in advanced hepatocellular carcinoma: a pilot study. Eur Radiol 2011;21:281–90

    CrossRefPubMed
13. 13.↵
    1. Barnes L,
    2. Eveson JW,
    3. Reichart P,
    4. et al

    . Pathology and Genetics of Head and Neck Tumours. Lyon, France: IARC Press; 2005
14. 14.↵
    1. Swerdlow SH,
    2. Campo E,
    3. Harris NL,
    4. et al

    . WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: IARC Press; 2008
15. 15.↵
    1. Ash L,
    2. Teknos TN,
    3. Gandhi D,
    4. et al

    . Head and neck squamous cell carcinoma: CT perfusion can help noninvasively predict intratumoral microvessel density. Radiology 2009;251:422–28

    CrossRefPubMed
16. 16.↵
    1. Clark CA,
    2. Le Bihan D

    . Water diffusion compartmentation and anisotropy at high b values in the human brain. Magn Reson Med 2000;44:852–59

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Bisdas S,
    2. Baghi M,
    3. Wagenblast J,
    4. et al

    . Differentiation of benign and malignant parotid tumors using deconvolution-based perfusion CT imaging: feasibility of the method and initial results. Eur J Radiol 2007;64:258–65

    CrossRefPubMed
18. 18.↵
    1. Abdel Razek A,
    2. Gaballa G

    . Role of perfusion magnetic resonance imaging in cervical lymphadenopathy. J Comput Assist Tomogr 2011;35:21–25

    CrossRefPubMed
19. 19.↵
    1. Schraml C,
    2. Boss A,
    3. Martirosian P,
    4. et al

    . FAIR true-FISP perfusion imaging of the thyroid gland. J Magn Reson Imaging 2007;26:66–71

    CrossRefPubMed
20. 20.↵
    1. Shah G,
    2. Wesolowski J,
    3. Ansari S,
    4. et al

    . New directions in head and neck imaging. J Surg Oncol 2008;97:644–48

    CrossRefPubMed
21. 21.↵
    1. Hermans R,
    2. Meijerink M,
    3. Van den Bogaert W,
    4. et al

    . Tumor perfusion rate determined noninvasively by dynamic computed tomography predicts outcome in head-and-neck cancer after radiotherapy. Int J Radiat Oncol Biol Phys 2003;57:1351–56

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Bisdas S,
    2. Rumboldt Z,
    3. Šurlan-Popovič K,
    4. et al

    . Perfusion CT in squamous cell carcinoma of the upper aerodigestive tract: long-term predictive value of baseline perfusion CT measurements. AJNR Am J Neuroradiol 2010;31:576–81

    Abstract/FREE Full Text
23. 23.↵
    1. Bisdas S,
    2. Nguyen SA,
    3. Anand SK,
    4. et al

    . Outcome prediction after surgery and chemoradiation of squamous cell carcinoma in the oral cavity, oropharynx, and hypopharynx: use of baseline perfusion CT microcirculatory parameters vs. tumor volume. Int J Radiat Oncol Biol Phys 2009;73:1313–18

    PubMed
24. 24.↵
    1. Sumi M,
    2. Ichikawa Y,
    3. Nakamura T

    . Diagnostic ability of apparent diffusion coefficients for lymphomas and carcinomas in the pharynx. Eur Radiol 2007;17:2631–37

    CrossRefPubMed